| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |